Ensures applicable interactions are aligned with enterprise and medical strategies and ultimately serve to ensure patients have access to BMS medicines through their efforts to ensure the medical community is fully apprised of their safe and effective use. Medical engagement Effectively collaborates and engages in scientific dialogue with TLs to gain insights on clinical landscape to ensure development of a medical plan that is both product/disease area focused and translates into effective launch Proactively engages in scientific and clinical conversation to ensure development of a medical plan that is both product/disease area focused and translates into effective launch and LCM activities. Engages with medical societies, PAGs (Patient Advocacy Groups) and guideline committee members as appropriate. Provides training for external speakers as needed. Strategically engages payers in the pre- and peri-launch phases (with fHEOR and Account Executives). Provides medical support to address unsolicited HCP questions in real-time, both in face-to-face interactions and through the Medical on Call virtual capability. Develops credible connections with key Thought Leaders (TLs) in [TA name] through high-quality peer-to-peer scientific dialogue. Appropriately document and achieve annual goals Leverages digital capabilities to enhance medical engagement Provides recommendations and insights to clinical development team on study feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO. Support Interventional and Non-Interventional Research (NIR) studies (e.g. identification and assessment of potential study sites) to facilitate patient recruitment and/or discussions around the safe and effective use of BMS investigational products, as agreed with home office medical and Global Development Operations (GDO) and as defined by the study scope document Provide recommendations and insights to clinical development team on study and site feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO Support HCPs in the ISR submission and execution process and study follow-up as agreed upon with home office medical and GDO Ensure that BMS Pharmacovigilance procedural documents are understood and applied by investigators of local studies, and alert appropriate BMS personnel to any identified Adverse Events Ability to work independently and act as a team player by developing strong rapport and working relationships with external and internal stakeholders. Knowledge of the national healthcare and access environments. Deep knowledge and experience of RWE. Ability to interpret RWE and identify opportunities for RWE projects. Be a representative of BMS in all interactions with external stakeholders. Holds a high level of integrity and good judgment, to navigate the requirements of the role effectively and compliantly in accordance with BMS policies and procedures. Work-life programs include paid national holidays and optional holidays, Global Shutdown Days between Christmas and New Year's holiday, up to 120 hours of paid vacation, up to two (2) paid days to volunteer, sick time off, and summer hours flexibility. Supporting People with Disabilities MD, DO, PharmD, DNP, or PhD required Minimum 3 years clinical or research experience in hematology OR 3 years as a medical science liaison in lymphoma or multiple myeloma disease landscapes Cell therapy experience strongly preferred Proven ability to work independently as well as in cross-functional teams Current working knowledge of US legal, regulatory, and compliance regulations and guidelines relevant to industry interactions with health-care professionals Ability to partner and maintain relationships within the medical community Excellent communication, presentation and time management skills Translating scientific or clinical data into an understandable and valuable information to help physicians best serve their patient's Scientific Agility - Ability to engage in a dialogue about data in a compelling, fair and balanced way and explain in a manner that resonates with TLs/HCPs - Expert knowledge of clinical practice and evolving healthcare delivery models. - Ability to understand and critically appraise scientific publications. - Knowledge of clinical trial design and methodology, including Good Clinical Practices and ethical, governmental, and regulatory requirements. - Understands treatment paradigms, competitive landscape and can frame information in a convincing and compliant way that resonates with physicians treating patients with lymphoma, multiple myeloma, and autoimmune diseases - Excellent communication and presentation skills to articulate scientific and clinical data in an easy-to-understand manner to help HCPs best serve their patients. - Has a strong learning mindset and passion for science. Prioritizes staying current with the latest data. Experience identifying, engaging, and cultivating relationships with HCPs. Ability to analyze data, such as market trends, and HCP preferences. Ability to segment HCPs based on their preferences and other relevant factors. Ability to derive actionable insights from data and analytics, including CE^3 analytics engine. Ability to use the Medical on Call technology effectively.